Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Changzhou Qianhong Biopharma CO.,LTD
| Okres |
2023-12-31 |
2024-12-31 |
2025-12-31 |
2026-12-31 |
| Przychód (średnia) |
1,965.00 |
1,957.00 |
2,255.00 |
2,729.00 |
| Przychód Δ r/r |
0.00% |
-0.41% |
15.23% |
21.02% |
| Przychód (min) |
1,897.50 |
1,888.16 |
2,158.00 |
2,621.59 |
| Przychód (max) |
2,032.50 |
2,025.84 |
2,352.00 |
2,836.41 |
| EBITDA (średnia) |
331.90 |
330.55 |
380.88 |
460.94 |
| EBIT (średnia) |
251.63 |
250.60 |
288.76 |
349.46 |
| EBIT % |
12.81% |
12.81% |
12.81% |
12.81% |
| Zysk netto (średni) |
229.46 |
305.95 |
369.69 |
420.68 |
| Zysk netto % |
11.68% |
15.63% |
16.39% |
15.42% |
| EPS (średnia) |
0.18 |
0.24 |
0.29 |
0.33 |
| Liczba analityków (Przychody) |
2 |
2 |
2 |
1 |
| Liczba analityków (EPS) |
3 |
2 |
2 |
0 |
| symbol |
002550.SZ |
002550.SZ |
002550.SZ |
002550.SZ |